Pyruvate carboxylase deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

Pyruvate carboxylase deficiency

Synonyms: Ataxia with lactic acidosis type 2 | Ataxia with lactic acidosis type II | Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency | Leigh syndrome due to PC deficiency | Leigh syndrome due to pyruvate carboxylase deficiency

Pyruvate carboxylase (PC) deficiency is a rare neurometabolic disorder characterized by metabolic acidosis failure to thrive developmental delay and recurrent seizures at an early age in severely affected patients.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Pyruvate carboxylase deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

The Mito Foundation

Mito Foundation is Australia’s peak body dedicated to supporting and empowering people affected by mitochondrial disease (mito). Our mission is to be the catalyst of energy, hope and cures for every Australian impacted by mito. Mito is a debilitating genetic disorder that robs the body’s cells of energy, causing single or multiple organ dysfunction or failure, and in many instances death.

Clinical Trials

For a list of clinical trials in this disease area, please click here.